Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Research Support, Non-U.S. Gov't

Multicenter Study

Comparative Study

Randomized Controlled Trial

Systematic Review

Meta-Analysis

Network Meta-Analysis

Review

Observational Study

Clinical Trial

Clinical Trial, Phase II

Clinical Trial, Phase IV

Video-Audio Media

Equivalence Trial

Research Support, N.I.H., Extramural

Publication Year

From

Quick links

Individual year

2025

2024

2022

2021

2020

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Dual Anti-Platelet Therapy""[mesh_terms]

26 Results

Searching titles within these results

Indications and Evidence for Dual Antiplatelet Therapy After Acute Ischemic Stroke.

Jessica Ringler, Mackenzie Steck, Samarth P Shah, Katleen W Chester

Critical care nursing quarterly 2020;43(2):122-137

Full Text

Abstract

De-Escalation of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndromes.

Satoshi Shoji, Toshiki Kuno, Tomohiro Fujisaki, Hisato Takagi, Alexandros Briasoulis, Pierre Deharo, Thomas Cuisset, Azeem Latib, Shun Kohsaka

Journal of the American College of Cardiology 2021;78(8):763-777

Free Full Text

Abstract

P2Y inhibitor monotherapy and dual antiplatelet therapy after percutaneous coronary intervention: An updated meta-analysis of randomized trials.

Yao Jin, Hui Huang, Xinyi Shu, Shuai Chen, Lin Lu, Xiang Gao, Zhijun Wu

Thrombosis research 2021;198():115-121

Full Text

Abstract

Comparison of Unguided De-Escalation Versus Guided Selection of Dual Antiplatelet Therapy After Acute Coronary Syndrome: A Systematic Review and Network Meta-Analysis.

Toshiki Kuno, Tomohiro Fujisaki, Satoshi Shoji, Yuki Sahashi, Yusuke Tsugawa, Masao Iwagami, Hisato Takagi, Alexandros Briasoulis, Pierre Deharo, Thomas Cuisset, Azeem Latib, Shun Kohsaka, Deepak L Bhatt

Circulation. Cardiovascular interventions 2022;15(8):e011990

Full Text

Abstract

Pooled Analysis of Bleeding, Major Adverse Cardiovascular Events, and All-Cause Mortality in Clinical Trials of Time-Constrained Dual-Antiplatelet Therapy After Percutaneous Coronary Intervention.

John D McClure, Jennifer C Ramsay, Colin Berry

Journal of the American Heart Association 2021;9(16):e017109

Free Full Text

Abstract

Reexamination of the Embolic Stroke of Undetermined Source Concept.

Gregory W Albers, Richard Bernstein, Johannes Brachmann, A John Camm, Peter Fromm, Shinya Goto, Christopher B Granger, Stefan H Hohnloser, Elaine Hylek, Derk Krieger, Rod Passman, Jesse M Pines, Peter Kowey

Stroke 2022;52(8):2715-2722

Full Text

Abstract

Outcomes Associated With Clopidogrel-Aspirin Use in Minor Stroke or Transient Ischemic Attack: A Pooled Analysis of Clopidogrel in High-Risk Patients With Acute Non-Disabling Cerebrovascular Events (CHANCE) and Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trials.

Yuesong Pan, Jordan J Elm, Hao Li, J Donald Easton, Yilong Wang, Mary Farrant, Xia Meng, Anthony S Kim, Xingquan Zhao, William J Meurer, Liping Liu, Dennis Dietrich, Yongjun Wang, S Claiborne Johnston

JAMA neurology 2021;76(12):1466-1473

Free Full Text

Abstract

Comparison of Ticagrelor Versus Clopidogrel on Cerebrovascular Microembolic Events and Platelet Inhibition during Transcatheter Aortic Valve Implantation.

Michael A Vavuranakis, Charalampos Kalantzis, Vassilis Voudris, Elias Kosmas, Konstantinos Kalogeras, Efstratios Katsianos, Evaggelos Oikonomou, Gerasimos Siasos, Konstantinos Aznaouridis, Konstantinos Toutouzas, Myrsini Stasinopoulou, Argyro Tountopoulou, Evangelia Bei, Carmen M Moldovan, Dimitrios Vrachatis, Ioannis Iakovou, Theodore G Papaioannou, Dimitrios Tousoulis, Thorsten M Leucker, Manolis Vavuranakis

The American journal of cardiology 2021;154():78-85

Full Text

Abstract

Aspirin-Free Strategy for Percutaneous Coronary Intervention in Patients With Oral Anticoagulation: Prespecified Subgroup Analysis From the STOPDAPT-3 Trial.

Ryusuke Nishikawa, Tsuyoshi Isawa, Mitsuru Ishii, Yohei Kobayashi, Yoichi Nozaki, Ryuichi Kato, Tetsuzo Wakatsuki, Takeshi Morimoto, Masahiro Natsuaki, Hiroyuki Takenaka, Hideki Kitahara, Minoru Yamada, Kenji Ando, Takeshi Kimura, Tetsuya Ishikawa, Koh Ono, Satoru Suwa, Ko Yamamoto, Hirotoshi Watanabe, Yuki Obayashi, Ryoma Kawai, Yoshitaka Goto

Journal of the American Heart Association 2024;13(15):e034201

Free Full Text

Abstract

Role of Proton Pump Inhibitors in Prevention of Upper Gastrointestinal Bleeding in Patients on Dual Antiplatelet Therapy: Systematic Review and Meta-Analysis.

Soban Ahmad, Umar Hayat, Michael Fine, Manesh Kumar Gangwani, Umer Farooq, Faisal Kamal, Muhammad Ali Khan, Muhammad Aziz, Aamir Saeed, Saira Yousuf, Marjan Haider, Ali Yazdani, Nicholas Noverati

American journal of therapeutics 2025;32(3):e256-e261

Full Text

Abstract

Trends of Antithrombotic Treatment in Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention: Insights from the GReek-AntiPlatElet Atrial Fibrillation (GRAPE-AF) Registry.

Despoina-Rafailia Benetou, Charalampos Varlamos, Dimitrios Alexopoulos, Dionysios Ktenas, Ioannis Tsiafoutis, Michael Koutouzis, Theodora Bampali, Christos Mantis, John Zarifis, Emmanouil Skalidis, Dionysios Aravantinos, Dimitrios Varvarousis, Ioannis Lianos, John Kanakakis, Evangelos Pisimisis, Antonios Ziakas, Periklis Davlouros

Cardiovascular drugs and therapy 2021;35(1):11-20

Full Text

Abstract

Caffeinated Beverage Intake, Dyspnea With Ticagrelor, and Cardiovascular Outcomes: Insights From the PEGASUS-TIMI 54 Trial.

Remo H M Furtado, Ramkumar V Venkateswaran, Jose C Nicolau, Yared Gurmu, Deepak L Bhatt, Robert F Storey, P Gabriel Steg, Giuglia Magnani, Shinya Goto, Mikael Dellborg, Gabriel Kamensky, Daniel Isaza, Philip Aylward, Per Johanson, Marc P Bonaca

Journal of the American Heart Association 2021;9(10):e015785

Free Full Text

Abstract

Duration of Dual Antiplatelet Therapy for Patients at High Bleeding Risk Undergoing PCI.

Marco Valgimigli, Davide Cao, Dominick J Angiolillo, Sripal Bangalore, Deepak L Bhatt, Junbo Ge, James Hermiller, Raj R Makkar, Franz-Josef Neumann, Shigeru Saito, Hector Picon, Ralph Toelg, Aziz Maksoud, Bassem M Chehab, James W Choi, Gianluca Campo, Jose M De la Torre Hernandez, Vijay Kunadian, Gennaro Sardella, Holger Thiele, Olivier Varenne, Pascal Vranckx, Stephan Windecker, Yujie Zhou, Mitchell W Krucoff, Karine Ruster, Yan Zheng, Roxana Mehran

Journal of the American College of Cardiology 2021;78(21):2060-2072

Free Full Text

Abstract

Safety and Efficacy of Double Antithrombotic Therapy With Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis.

Davide Capodanno, Marco Di Maio, Antonio Greco, Deepak L Bhatt, C Michael Gibson, Andreas Goette, Renato D Lopes, Roxana Mehran, Pascal Vranckx, Dominick J Angiolillo

Journal of the American Heart Association 2021;9(16):e017212

Free Full Text

Abstract

Risk of Stroke vs. Intracerebral Hemorrhage in Patients with Non-Valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Comparing Dual vs. Triple Antithrombotic Therapy.

Aaron Desai, Cesar Escamilla-Ocanas, Deepika Dilip, Hamidreza Saber, Rahul Damani

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2021;30(4):105654

Full Text

Abstract

Results: 1 – 15 / 26

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Dual Anti-Platelet Therapy""[mesh_terms]

Indications and Evidence for Dual Antiplatelet Therapy After Acute Ischemic Stroke.

De-Escalation of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndromes.

P2Y inhibitor monotherapy and dual antiplatelet therapy after percutaneous coronary intervention: An updated meta-analysis of randomized trials.

Comparison of Unguided De-Escalation Versus Guided Selection of Dual Antiplatelet Therapy After Acute Coronary Syndrome: A Systematic Review and Network Meta-Analysis.

Pooled Analysis of Bleeding, Major Adverse Cardiovascular Events, and All-Cause Mortality in Clinical Trials of Time-Constrained Dual-Antiplatelet Therapy After Percutaneous Coronary Intervention.

Reexamination of the Embolic Stroke of Undetermined Source Concept.

Outcomes Associated With Clopidogrel-Aspirin Use in Minor Stroke or Transient Ischemic Attack: A Pooled Analysis of Clopidogrel in High-Risk Patients With Acute Non-Disabling Cerebrovascular Events (CHANCE) and Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trials.

Comparison of Ticagrelor Versus Clopidogrel on Cerebrovascular Microembolic Events and Platelet Inhibition during Transcatheter Aortic Valve Implantation.

Aspirin-Free Strategy for Percutaneous Coronary Intervention in Patients With Oral Anticoagulation: Prespecified Subgroup Analysis From the STOPDAPT-3 Trial.

Role of Proton Pump Inhibitors in Prevention of Upper Gastrointestinal Bleeding in Patients on Dual Antiplatelet Therapy: Systematic Review and Meta-Analysis.

Trends of Antithrombotic Treatment in Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention: Insights from the GReek-AntiPlatElet Atrial Fibrillation (GRAPE-AF) Registry.

Caffeinated Beverage Intake, Dyspnea With Ticagrelor, and Cardiovascular Outcomes: Insights From the PEGASUS-TIMI 54 Trial.

Duration of Dual Antiplatelet Therapy for Patients at High Bleeding Risk Undergoing PCI.

Safety and Efficacy of Double Antithrombotic Therapy With Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis.

Risk of Stroke vs. Intracerebral Hemorrhage in Patients with Non-Valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Comparing Dual vs. Triple Antithrombotic Therapy.

Results for
""Dual Anti-Platelet Therapy""[mesh_terms]